Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing
spondylitis (AS) in the GO‐RAISE study. Methods Patients with active AS, a Bath AS Disease …

Aims Our study sought to assess the prevalence of and risk factors for opioid drug
dependence among out‐patients on long‐term opioid therapy in a large health‐care system …

Objective. To identify disease characteristics lead-ing to progression of joint damage in
patients with early rheumatoid arthritis (RA) treated with methotrexate (MTX) versus those …

Objective To assess the efficacy, safety, and pharmacology of subcutaneous administration
of golimumab in patients with active rheumatoid arthritis (RA) despite treatment with …

Objective To assess the risk of serious infections following 22 weeks of infliximab therapy,
and to further characterize the safety profile of infliximab in combination with background …

Objective: To examine the association of radiographic progression and disease activity
states in patients with rheumatoid arthritis (RA) treated with methotrexate with or without …

OBJECTIVE: To evaluate the effect of antitumor necrosis factor-alpha monoclonal antibody
infliximab treatment on anemia in patients with rheumatoid arthritis (RA). METHODS: Data …

Objective To determine whether the effects of anti–tumor necrosis factor α (TNFα) in
reducing the signs and symptoms of ankylosing spondylitis (AS) coincide with a reduction in …

The authors estimated the prevalence of lifetime prescription opioid-use disorder among
outpatients on opioid therapy using criteria from both versions 4 and 5 of the Diagnostic and …

Objectives: To evaluate the relationship between bone mineral density (BMD) and
biomarkers of bone turnover and inflammation in patients with ankylosing spondylitis (AS) …